Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW)vsVertex Pharmaceuticals Inc (VRTX)
PSNYW
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
$5.33
+0.19%
CONSUMER CYCLICAL · Cap: $34.90B
VRTX
Vertex Pharmaceuticals Inc
$454.97
+1.42%
HEALTHCARE · Cap: $113.95B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 371% more annual revenue ($12.00B vs $2.55B). VRTX leads profitability with a 32.9% profit margin vs -106.0%. VRTX earns a higher WallStSmart Score of 66/100 (B-).
PSNYW
Avoid34
out of 100
Grade: F
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for PSNYW.
Margin of Safety
+36.5%
Fair Value
$716.04
Current Price
$454.97
$261.07 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 26.1% year-over-year
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 23 in profit
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : PSNYW
The strongest argument for PSNYW centers on Revenue Growth. Revenue growth of 26.1% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.
Bear Case : PSNYW
The primary concerns for PSNYW are EPS Growth, Return on Equity, Free Cash Flow.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
PSNYW profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.
PSNYW carries more volatility with a beta of 1.65 — expect wider price swings.
PSNYW is growing revenue faster at 26.1% — sustainability is the question.
VRTX generates stronger free cash flow (349M), providing more financial flexibility.
Bottom Line
VRTX scores higher overall (66/100 vs 34/100), backed by strong 32.9% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA
Polestar Automotive Holding UK PLC (Ticker: PSNYW) is a leading contender in the electric performance vehicle market, distinguished by its commitment to innovation and sustainability. As a subsidiary of Volvo Cars and Geely, Polestar leverages cutting-edge technology and engineering to create high-performance electric vehicles, exemplified by its flagship model, the Polestar 2, which integrates exceptional design with advanced connectivity features. The company is strategically enhancing its global presence and production capabilities, positioning itself to capitalize on the rapid growth of the electric vehicle sector and play a pivotal role in the transition towards a sustainable automotive future.
Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other AUTO MANUFACTURERS Stocks
Want to dig deeper into these stocks?